LBRX
NASDAQ · Pharmaceuticals
Lb Pharmaceuticals Inc
$24.21
+0.84 (+3.59%)
Open$23.52
Previous Close$23.37
Day High$24.60
Day Low$22.84
52W High$27.55
52W Low$13.36
Volume—
Avg Volume265.1K
Market Cap612.11M
P/E Ratio—
EPS$-0.82
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
-37.2% upside
Current
$24.21
$24.21
Target
$15.21
$15.21
$11.61
$15.21 avg
$18.52
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 167.53M | 154.99M | 171.21M |
| Net Income | 47.95M | 36.94M | 41.17M |
| Profit Margin | 28.6% | 23.8% | 24.1% |
| EBITDA | 61.52M | 61.45M | 59.09M |
| Free Cash Flow | 46.38M | 48.44M | 62.84M |
| Rev Growth | -8.2% | -9.0% | +5.4% |
| Debt/Equity | 1.06 | 1.00 | 0.91 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |